Credit: Data adapted from Wong ND et al., Cardiovasc Drug Ther 2023.
Estimated 10-Year Cardiovascular Disease Risk and Projected Number of Cardiovascular Events (in Millions) in 10 Years Without and With Semaglutide Treatment, Among US Adults without Cardiovascular Disease but with Overweight or Obesity.